Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Mycopathologia ; 174(5-6): 421-8, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22932958

RESUMO

In the present study, the in vitro susceptibility and capsular width from both melanized and non-melanized Cryptococcus neoformans cells in the presence of Pimenta pseudocaryophyllus crude extract were determined. The results were compared with those obtained for voriconazole and amphotericin B. Melanization was obtained in minimal medium broth with the addition of L-dopa, and the antifungal susceptibility tests were performed using the broth microdilution method. Capsular width of 30 cells of each one of the isolates in medium with crude extracts of P. pseudocaryophyllus or voriconazole or amphotericin B at a concentration corresponding to 0.5 times the minimal inhibitory concentration (MIC) was measured, and the mean was calculated. The MICs and minimal fungicidal concentrations (MFCs) for plant extract and voriconazole were identical for both melanized and non-melanized C. neoformans isolates, but for amphotericin, the MFCs for melanized cells were up to 8 times higher than for non-melanized cells. The capsular width of C. neoformans cells was smaller (p < 0.001) in the presence crude extract of P. pseudocaryophyllus and of voriconazole regardless melanization. The findings of capsule alterations of C. neoformans verified in this study provide fertile ways for future research into the effects of antifungal agents on the pathogenesis of cryptococcosis.


Assuntos
Antifúngicos/farmacologia , Cryptococcus neoformans/efeitos dos fármacos , Melaninas/metabolismo , Pimenta/química , Extratos Vegetais/farmacologia , Anfotericina B/farmacologia , Criptococose/microbiologia , Cryptococcus neoformans/química , Cryptococcus neoformans/metabolismo , Farmacorresistência Fúngica , Cápsulas Fúngicas/química , Cápsulas Fúngicas/metabolismo , Humanos , Testes de Sensibilidade Microbiana , Pirimidinas/farmacologia , Triazóis/farmacologia , Voriconazol
2.
Mycopathologia ; 169(2): 91-8, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19685156

RESUMO

Some antifungal agents have shown to exert effects on expression of virulent factors of Candida as the production of secretory aspartyl proteinase (Sap). In this study, we sought to determine and to compare the influence of fluconazole and voriconazole in proteinase activity of this microorganism. Thirty-one isolates obtained from oral mucosa of human immunodeficiency virus positive (HIV) patients were used in this study. The minimal inhibitory concentrations (MIC) of fluconazole and voriconazole were determined using the broth microdilution method with RPMI 1640 medium and with yeast carbon base-bovine serum albumin (YCB-BSA) medium. The Sap activity following by digestion of BSA as substrate was determined for four Candida albicans strains arbitrarily chosen according to susceptibility (susceptible or resistant) to fluconazole or voriconazole. Besides, the SAP1 to SAP7 genes were screened by PCR for the same isolates that were determined by the Sap activity. In vitro susceptibility testing using the two media presented similar MIC values. Increased Sap activity was observed in resistant isolates on presence of drugs, but the Sap activity by susceptible isolates to azoles showed different behavior on the presence of drug. We detected the presence of SAP1 to SAP7 genes from all susceptible or resistant C. albicans isolates. The present study provides important data about the proteinase activity and the presence of genes of SAP family in fluconazole and voriconazole susceptible or resistant C. albicans isolates.


Assuntos
Antifúngicos/farmacologia , Ácido Aspártico Proteases/antagonistas & inibidores , Candida albicans/efeitos dos fármacos , Candida albicans/enzimologia , Fluconazol/farmacologia , Pirimidinas/farmacologia , Triazóis/farmacologia , Ácido Aspártico Proteases/genética , Candida albicans/isolamento & purificação , Candidíase/microbiologia , Meios de Cultura/química , DNA Fúngico/genética , Farmacorresistência Fúngica , Infecções por HIV/complicações , Humanos , Testes de Sensibilidade Microbiana , Mucosa Bucal/microbiologia , Reação em Cadeia da Polimerase/métodos , Voriconazol
3.
Int J Antimicrob Agents ; 29(3): 281-4, 2007 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-17223320

RESUMO

In this paper, we identified 95 Malassezia isolates by morphological and biochemical criteria and assessed the in vitro activity of fluconazole, itraconazole, ketoconazole and voriconazole by broth microdilution against these species using slightly modified Leeming-Notman medium. The Malassezia isolates were identified as M. furfur (74), M. sympodialis (11), M. obtusa (8) and M. globosa (2). The modified Leeming-Notman medium used for susceptibility testing allowed good growth of Malassezia spp. Visual reading of the minimal inhibitory concentration (MIC) was readily achieved until Day 5 of incubation at 32 degrees C. Although high MIC values of 16 microg/mL for fluconazole were observed in 9.5% of Malassezia isolates, in general these microorganisms were susceptible to all drugs studied. Interestingly, one M. globosa isolate showed high MIC values for voriconazole, itraconazole and fluconazole. For the 95 strains, the MIC ranges were <0.03-4 microg/mL for ketoconazole, <0.03 to >16 microg/mL for voriconazole, <0.125 to >64 microg/mL for fluconazole and <0.03-16 microg/mL for itraconazole. In summary, the good reproducibility and visual readings obtained using modified Leeming-Notman medium suggest that this medium should be proposed for antifungal testing of drugs against Malassezia spp.


Assuntos
Antifúngicos/farmacologia , Azóis/farmacologia , Malassezia/efeitos dos fármacos , Fluconazol/farmacologia , Humanos , Técnicas In Vitro , Itraconazol/farmacologia , Cetoconazol/farmacologia , Malassezia/isolamento & purificação , Malassezia/patogenicidade , Testes de Sensibilidade Microbiana , Pirimidinas/farmacologia , Tinha Versicolor/tratamento farmacológico , Tinha Versicolor/microbiologia , Triazóis/farmacologia , Voriconazol
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...